Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

Uldrick TS, Polizzotto MN, Aleman K, O'Mahony D, Wyvill KM, Wang V, Marshall V, Pittaluga S, Steinberg SM, Tosato G, Whitby D, Little RF, Yarchoan R.

Blood. 2011 Jun 30;117(26):6977-86. doi: 10.1182/blood-2010-11-317610. Epub 2011 Apr 12.

2.

Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.

Uldrick TS, Polizzotto MN, Aleman K, Wyvill KM, Marshall V, Whitby D, Wang V, Pittaluga S, O'Mahony D, Steinberg SM, Little RF, Yarchoan R.

Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.

3.

Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Uldrick TS, Polizzotto MN, Yarchoan R.

Curr Opin Oncol. 2012 Sep;24(5):495-505. doi: 10.1097/CCO.0b013e328355e0f3. Review.

PMID:
22729151
4.

An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R.

Clin Infect Dis. 2010 Aug 1;51(3):350-8. doi: 10.1086/654798.

5.

Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG.

Blood. 2001 Apr 1;97(7):2130-6. Erratum in: Blood 2001 Jun 1;97(11):3678.

6.

18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.

Polizzotto MN, Millo C, Uldrick TS, Aleman K, Whatley M, Wyvill KM, O'Mahony D, Marshall V, Whitby D, Maass-Moreno R, Steinberg SM, Little RF, Yarchoan R.

J Infect Dis. 2015 Oct 15;212(8):1250-60. doi: 10.1093/infdis/jiv204. Epub 2015 Mar 31.

7.

Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).

Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM.

Histopathology. 2008 Nov;53(5):513-24. doi: 10.1111/j.1365-2559.2008.03144.x.

PMID:
18983461
8.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC, Hamoudi R, Daniel MT, Agbalika F, Boshoff C, Clauvel JP, Isaacson PG, Meignin V.

Blood. 2002 Apr 1;99(7):2331-6.

9.

KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.

Carbone A, De Paoli P, Gloghini A, Vaccher E.

Int J Cancer. 2015 Jul 15;137(2):251-61. doi: 10.1002/ijc.28923. Epub 2014 May 5. Review.

10.

Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Venkataraman G, Uldrick TS, Aleman K, O'Mahony D, Karcher DS, Steinberg SM, Raffeld MA, Marshall V, Whitby D, Little RF, Yarchoan R, Pittaluga S, Maric I.

Am J Clin Pathol. 2013 May;139(5):651-61. doi: 10.1309/AJCPKGF7U8AWQBVG.

PMID:
23596117
11.

Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.

Hu D, Wang V, Yang M, Abdullah S, Davis DA, Uldrick TS, Polizzotto MN, Veeranna RP, Pittaluga S, Tosato G, Yarchoan R.

J Virol. 2015 Oct 21;90(1):368-78. doi: 10.1128/JVI.01192-15.

12.

Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

Casper C, Nichols WG, Huang ML, Corey L, Wald A.

Blood. 2004 Mar 1;103(5):1632-4. Epub 2003 Nov 13.

13.

Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.

Simonelli C, Tedeschi R, Gloghini A, Talamini R, Bortolin MT, Berretta M, Spina M, Morassut S, Vaccher E, De Paoli P, Carbone A, Tirelli U.

J Med Virol. 2009 May;81(5):888-96. doi: 10.1002/jmv.21349.

PMID:
19319955
14.

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

Polizzotto MN, Uldrick TS, Wang V, Aleman K, Wyvill KM, Marshall V, Pittaluga S, O'Mahony D, Whitby D, Tosato G, Steinberg SM, Little RF, Yarchoan R.

Blood. 2013 Dec 19;122(26):4189-98. doi: 10.1182/blood-2013-08-519959. Epub 2013 Oct 30.

15.

Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.

Marcelin AG, Motol J, Guihot A, Caumes E, Viard JP, Dussaix E, Cadranel J, Frances C, Carcelain G, Calvez V, Dupin N.

J Infect Dis. 2007 Oct 15;196(8):1163-6. Epub 2007 Sep 11.

PMID:
17955434
16.

Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome.

Ray A, Marshall V, Uldrick T, Leighty R, Labo N, Wyvill K, Aleman K, Polizzotto MN, Little RF, Yarchoan R, Whitby D.

J Infect Dis. 2012 Jun;205(11):1665-76. doi: 10.1093/infdis/jis249. Epub 2012 Mar 23.

17.

The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.

Haq IU, Dalla Pria A, Papanastasopoulos P, Stegmann K, Bradshaw D, Nelson M, Bower M.

HIV Med. 2016 Jan;17(1):56-61. doi: 10.1111/hiv.12273. Epub 2015 Jun 25.

PMID:
26111246
18.

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.

Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST.

Leukemia. 2005 May;19(5):851-5.

PMID:
15744337
19.

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.

Polizzotto MN, Uldrick TS, Hu D, Yarchoan R.

Front Microbiol. 2012 Mar 2;3:73. doi: 10.3389/fmicb.2012.00073. eCollection 2012.

20.

Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS).

Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Marshall V, Wang V, Whitby D, Pittaluga S, Jaffe ES, Millo C, Tosato G, Little RF, Steinberg SM, Sereti I, Yarchoan R.

Clin Infect Dis. 2016 Mar 15;62(6):730-738. doi: 10.1093/cid/civ996. Epub 2015 Dec 12.

Supplemental Content

Support Center